Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2020 3
2021 3
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
A randomized trial evaluating virus-specific effects of a combination probiotic in children with acute gastroenteritis.
Freedman SB, Xie J, Nettel-Aguirre A, Pang XL, Chui L, Williamson-Urquhart S, Schnadower D, Schuh S, Sherman PM, Lee BE, Gouin S, Farion KJ, Poonai N, Hurley KF, Qiu Y, Ghandi B, Lloyd C, Finkelstein Y; Pediatric Emergency Research Canada Probiotic (PERC) Regimen for Outpatient Gastroenteritis Utility of Treatment (PROGUT) Trial Group. Freedman SB, et al. Among authors: lloyd c. Nat Commun. 2020 May 21;11(1):2533. doi: 10.1038/s41467-020-16308-3. Nat Commun. 2020. PMID: 32439860 Free PMC article. Clinical Trial.
Comparative Evaluation of Luminex xTAG® Gastrointestinal Pathogen Panel and Direct-From-Stool Real-Time PCR for Detection of C. difficile Toxin tcdB in Stool Samples from a Pediatric Population.
Tyrrell H, Morin SBN, Lloyd CD, Parsons B, Stokowski T, Xie J, Zhuo R, Lee BE, Pang XL, Freedman SB, Chui L. Tyrrell H, et al. Among authors: lloyd cd. Microorganisms. 2022 Nov 9;10(11):2214. doi: 10.3390/microorganisms10112214. Microorganisms. 2022. PMID: 36363805 Free PMC article.
The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial.
Kao D, Wong K, Franz R, Cochrane K, Sherriff K, Chui L, Lloyd C, Roach B, Bai AD, Petrof EO, Allen-Vercoe E. Kao D, et al. Among authors: lloyd c. Lancet Gastroenterol Hepatol. 2021 Apr;6(4):282-291. doi: 10.1016/S2468-1253(21)00007-8. Epub 2021 Feb 23. Lancet Gastroenterol Hepatol. 2021. PMID: 33631102 Clinical Trial.